Literature DB >> 17008314

Myeloid leukemia factor 1 associates with a novel heterogeneous nuclear ribonucleoprotein U-like molecule.

Louise N Winteringham1, Raelene Endersby, Simon Kobelke, Ross K McCulloch, James H Williams, Justin Stillitano, Scott M Cornwall, Evan Ingley, S Peter Klinken.   

Abstract

Myeloid leukemia factor 1 (MLF1) is an oncoprotein associated with hemopoietic lineage commitment and acute myeloid leukemia. Here we show that Mlf1 associated with a novel binding partner, Mlf1-associated nuclear protein (Manp), a new heterogeneous nuclear ribonucleoprotein (hnRNP) family member, related to hnRNP-U. Manp localized exclusively in the nucleus and could redirect Mlf1 from the cytoplasm into the nucleus. The nuclear content of Mlf1 was also regulated by 14-3-3 binding to a canonical 14-3-3 binding motif within the N terminus of Mlf1. Significantly Mlf1 contains a functional nuclear export signal and localized primarily to the nuclei of hemopoietic cells. Mlf1 was capable of binding DNA, and microarray analysis revealed that it affected the expression of several genes, including transcription factors. In summary, this study reveals that Mlf1 translocates between nucleus and cytoplasm, associates with a novel hnRNP, and influences gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008314     DOI: 10.1074/jbc.M605401200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Myeloid Leukemia Factor Acts in a Chaperone Complex to Regulate Transcription Factor Stability and Gene Expression.

Authors:  Jamie O Dyer; Arnob Dutta; Madelaine Gogol; Vikki M Weake; George Dialynas; Xilan Wu; Christopher Seidel; Ying Zhang; Laurence Florens; Michael P Washburn; Susan M Abmayr; Jerry L Workman
Journal:  J Mol Biol       Date:  2016-10-27       Impact factor: 5.469

2.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

3.  Distant homologs of anti-apoptotic factor HAX1 encode parvalbumin-like calcium binding proteins.

Authors:  Katarzyna Kokoszyńska; Leszek Rychlewski; Lucjan S Wyrwicz
Journal:  BMC Res Notes       Date:  2010-07-15

4.  Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis.

Authors:  Vanessa Gobert; Marc Haenlin; Lucas Waltzer
Journal:  Transcription       Date:  2012-09-01

5.  Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.

Authors:  Noriko Yoneda-Kato; Jun-Ya Kato
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

6.  Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.

Authors:  Yi Sun; Amina Fu; Wu Xu; Jyh-Rong Chao; Simon Moshiach; Stephan W Morris
Journal:  J Physiol Biochem       Date:  2015-11-12       Impact factor: 4.158

7.  Drosophila myeloid leukemia factor acts with DREF to activate the JNK signaling pathway.

Authors:  H Yanai; Y Yoshioka; H Yoshida; Y Nakao; A Plessis; M Yamaguchi
Journal:  Oncogenesis       Date:  2014-04-21       Impact factor: 7.485

8.  Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis.

Authors:  Marion Miller; Aichun Chen; Vanessa Gobert; Benoit Augé; Mathilde Beau; Odile Burlet-Schiltz; Marc Haenlin; Lucas Waltzer
Journal:  PLoS Genet       Date:  2017-07-25       Impact factor: 5.917

9.  Seten: a tool for systematic identification and comparison of processes, phenotypes, and diseases associated with RNA-binding proteins from condition-specific CLIP-seq profiles.

Authors:  Gungor Budak; Rajneesh Srivastava; Sarath Chandra Janga
Journal:  RNA       Date:  2017-03-23       Impact factor: 4.942

10.  Subcellular localization of full-length human myeloid leukemia factor 1 (MLF1) is independent of 14-3-3 proteins.

Authors:  Manuela Molzan; Christian Ottmann
Journal:  Cell Mol Biol Lett       Date:  2012-12-27       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.